Breast tissue collection

OTHER2 trials

Sponsors

Washington University School of Medicine, Columbia University

Conditions

Breast NeoplasmsHormone Receptor Positive Malignant Neoplasm of BreastTriple Negative Breast Cancer

Unknown Phase

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

RecruitingNCT00353483

Washington University School of MedicineBreast Neoplasms

Start: 2005-09-14End: 2026-08-31Target: 300Updated: 2025-11-28

Comparison of the Breast Tumor Microenvironment

Active, not recruitingNCT03165487

Columbia UniversityHormone Receptor Positive Malignant Neoplasm of Breast, Triple Negative Breast Cancer

Start: 2017-09-28End: 2027-12-01Updated: 2025-08-22

Related Papers

Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels

Biochemistry (Moscow)2020-06-2424 citations

Abstract P3-09-17: Preoperative pembrolizumab increases sTILs in treatment naïve stage I/IIA TNBC patients in a window of opportunity trial

Cancer Research2020-02-15

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.

2017-05-0159 citations